<DOC>
	<DOCNO>NCT02895737</DOCNO>
	<brief_summary>This prospective , randomize study design analyse difference cerebral embolization patient undergoing transcatheter aortic valve implantation balloon-expandable vs. self-expandable valve use cerebral protection system ( Claret Sentinel™ Device ) .</brief_summary>
	<brief_title>PROTECT TAVI - Prospective Randomized Outcome Study TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With Claret Sentinel™ Device</brief_title>
	<detailed_description />
	<criteria>Patients aortic stenosis indication transfemoral aortic valve replacement Freedom significant stenosis area Truncus brachiocephalicus leave A. carotis ( CT ) Necessary vessel diameter 6.510 mm area A. carotis communis sinistra 915 mm area Truncus brachiocephalicus ( delivery protection system ) Anomalies aortic arch ( `` bovine arch '' variant ) : 1 . Direct outflow leave A. carotis communis Truncus brachiocephalicus 2 . Conjoint origin Truncus brachiocephalicus leave A. carotis communis aortic arch The patient provide write informed consent Apoplexy/ TIA last ½ year Severe carotid stenosis ( &gt; 70 % ) Symptomatic asymptomatic carotid stenosis necessity TEA stenting Relevant psychiatric disease Severe/ relevant visual , auditory cognitive deficit impede target anamnesis , neurologic evaluation consenting . Severe neurodegenerative progressive neuromuscular disease state severe craniocerebral injury permanent neurologic sequelae structural cerebral disease Pronounced kinking/ stenosis calcification area right A. radialis/ brachialis/ subclavia , impede implantation cerebral protection system Significant stenosis , relevant calcification , dissection aneurysmatic alteration area Truncus brachiocephalicus and/or A. carotis communis sinistra . Contraindications MRI : among others presence nonMRIcompatible pacemaker defibrillator , metal implant area evaluate , metal fragment craniocerebral area , allergy , claustrophobia . Vessel alteration impede among others introduction 6 French sheath : 1 . Inadequate perfusion area right upper extremity ( pathologic Allen´s test , vessel obstruction , peripheral vascular disease ) 2 . Hemodialysis shunt , graft , arteriovenous fistula area right upper extremity Acute myocardial infarction ≤ 1 month prior plan procedure Every contraindication execution transfemoral TAVI Aortic annulus &lt; 19 &gt; 27 mm Combined aortic vitium predominant insufficiency . Severly reduce rightventricular function ≤ 20 % Patients plan hybrid procedure ( e.g . conventional operation TAVI simultaneous coronary intervention coronary artery disease need intervention ) 30 day prior plan study procedure Intracardiac thrombus , hematoma , tumor vegetation confirm echocardiography Endocarditis Planned concomitant procedure atrial fibrillation ( operative via catheter ablation ) follow phase Need emergency procedure Chronic drug , medication alcohol abuse Consuming disease Life expectancy &lt; 1 year Dialysis dependency Patient legal incapacity , able understand essence , mean consequence study Participation interventional clinical trial month study start plan participation participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>aortic stenosis , transcatheter aortic valve replacement , stroke , ischemic infarction , cerebral embolic protection device</keyword>
</DOC>